• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性气流阻塞的自然病史。

The natural history of chronic airflow obstruction.

作者信息

Fletcher C, Peto R

出版信息

Br Med J. 1977 Jun 25;1(6077):1645-8. doi: 10.1136/bmj.1.6077.1645.

DOI:10.1136/bmj.1.6077.1645
PMID:871704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1607732/
Abstract

A prospective epidemiological study of the early stages of the development of chronic obstructive pulmonary disease was performed on London working men. The findings showed that forced expiratory volume in one second (FEV1) falls gradually over a lifetime, but in most non-smokers and many smokers clinically significant airflow obstruction never develops. In susceptible people, however, smoking causes irreversible obstructive changes. If a susceptible smoker stops smoking he will not recover his lung function, but the average further rates of loss of FEV1 will revert to normal. Therefore, severe or fatal obstructive lung disease could be prevented by screening smokers' lung function in early middle age if those with reduced function could be induced to stop smoking. Infective processes and chronic mucus hypersecretion do not cause chronic airflow obstruction to progress more rapidly. There are thus two largely unrelated disease processes, chronic airflow obstruction and the hypersecretory disorder (including infective processes).

摘要

对伦敦在职男性进行了一项关于慢性阻塞性肺疾病早期发展阶段的前瞻性流行病学研究。研究结果表明,一秒用力呼气量(FEV1)在一生中会逐渐下降,但在大多数非吸烟者和许多吸烟者中,临床上显著的气流阻塞从未发生。然而,在易感人群中,吸烟会导致不可逆的阻塞性改变。如果易感吸烟者戒烟,其肺功能不会恢复,但FEV1的平均进一步下降速率将恢复正常。因此,如果能促使肺功能降低的吸烟者戒烟,那么通过在中年早期筛查吸烟者的肺功能,严重或致命的阻塞性肺病是可以预防的。感染过程和慢性黏液高分泌并不会使慢性气流阻塞进展得更快。因此,存在两个基本不相关的疾病过程,即慢性气流阻塞和高分泌性疾病(包括感染过程)。

相似文献

1
The natural history of chronic airflow obstruction.慢性气流阻塞的自然病史。
Br Med J. 1977 Jun 25;1(6077):1645-8. doi: 10.1136/bmj.1.6077.1645.
2
Epidemiology of bronchial hypersecretion: recent studies.
Eur J Respir Dis Suppl. 1987;153:13-8.
3
Relevance of airflow obstruction and mucus hypersecretion to mortality.气流阻塞和黏液高分泌与死亡率的相关性。
Respir Med. 1991 Jan;85(1):27-35. doi: 10.1016/s0954-6111(06)80207-6.
4
Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction.有和没有气流受限的既往吸烟者的肺动脉异常
COPD. 2016;13(2):224-34. doi: 10.3109/15412555.2015.1074666. Epub 2015 Nov 25.
5
Prevalence of airflow obstruction in smokers and never-smokers in Switzerland.瑞士烟民和非烟民中气流阻塞的流行情况。
Eur Respir J. 2010 Dec;36(6):1259-69. doi: 10.1183/09031936.00004110. Epub 2010 Apr 22.
6
Clinically remitted childhood asthma is associated with airflow obstruction in middle-aged adults.临床缓解的儿童哮喘与中年成年人的气流阻塞有关。
Respirology. 2017 Jan;22(1):86-92. doi: 10.1111/resp.12860. Epub 2016 Jul 21.
7
Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.在韩国人群中,使用FEV1/FEV6作为FEV1/FVC的替代指标来检测气道阻塞的截断值。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 19;11:1957-63. doi: 10.2147/COPD.S113568. eCollection 2016.
8
Comparison of forced expiratory volume in one second (FEV1) among asymptomatic smokers and non-smokers.无症状吸烟者与非吸烟者一秒用力呼气量(FEV1)的比较。
J Pak Med Assoc. 2010 Mar;60(3):209-13.
9
Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.通气功能损害及慢性黏液高分泌与阻塞性肺病及各种原因所致死亡率的关系。
Thorax. 1990 Aug;45(8):579-85. doi: 10.1136/thx.45.8.579.
10
COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers.吸烟者气流阻塞诊断标准与 COPD 预后的关系。
Eur Respir J. 2014 Jan;43(1):54-63. doi: 10.1183/09031936.00158212. Epub 2013 Apr 5.

引用本文的文献

1
Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities.
Nat Rev Drug Discov. 2025 Sep 22. doi: 10.1038/s41573-025-01290-6.
2
Digital health technologies for improving the management of people with chronic obstructive pulmonary disease.用于改善慢性阻塞性肺疾病患者管理的数字健康技术。
Front Digit Health. 2025 Aug 6;7:1640585. doi: 10.3389/fdgth.2025.1640585. eCollection 2025.
3
Chronic Obstructive Pulmonary Disease and Depression-The Vicious Mental Cycle.慢性阻塞性肺疾病与抑郁症——恶性循环
Healthcare (Basel). 2025 Jul 15;13(14):1699. doi: 10.3390/healthcare13141699.
4
Navigating data availability challenges in healthcare: assessing the added value of pulmonary function testing to the Care Assessment Need score for mortality risk.应对医疗保健领域的数据可用性挑战:评估肺功能测试对护理评估需求评分在死亡风险方面的附加价值。
BMJ Health Care Inform. 2025 Jul 20;32(1):e101361. doi: 10.1136/bmjhci-2024-101361.
5
A phenome-wide association study of genetically determined nicotine metabolism reveals novel links with health-related outcomes.一项关于基因决定的尼古丁代谢的全表型组关联研究揭示了与健康相关结局的新联系。
Eur J Epidemiol. 2025 Jul 12. doi: 10.1007/s10654-025-01270-5.
6
Health status, respiratory symptom and dyspnea trajectories in subjects with chronic obstructive pulmonary disease: a seven-year observation in clinical practice.慢性阻塞性肺疾病患者的健康状况、呼吸道症状及呼吸困难轨迹:临床实践中的七年观察
J Patient Rep Outcomes. 2025 Jul 11;9(1):88. doi: 10.1186/s41687-025-00923-z.
7
Towards early detection and disease interception of COPD across the lifespan.实现慢性阻塞性肺疾病(COPD)全生命周期的早期检测与疾病阻断。
Eur Respir Rev. 2025 Jul 9;34(177). doi: 10.1183/16000617.0243-2024. Print 2025 Jul.
8
Eosinophil count and treatment response in COPD patients.慢性阻塞性肺疾病(COPD)患者的嗜酸性粒细胞计数与治疗反应
Lung India. 2025 Jul 1;42(4):337-342. doi: 10.4103/lungindia.lungindia_630_24. Epub 2025 Jun 27.
9
Comparative analysis of pulmonary function decline in patients undergoing bronchoscopic lung volume reduction with endobronchial valves versus conservative treatment in emphysema management: A longitudinal coarsened exact matched analysis.支气管镜下肺减容术使用支气管内瓣膜与保守治疗在肺气肿管理中患者肺功能下降的比较分析:一项纵向粗化精确匹配分析
Chron Respir Dis. 2025 Jan-Dec;22:14799731251350709. doi: 10.1177/14799731251350709. Epub 2025 Jun 11.
10
Mucus: An Underestimated Player in Airway Diseases.黏液:气道疾病中被低估的因素
Lung. 2025 May 6;203(1):60. doi: 10.1007/s00408-025-00816-4.

本文引用的文献

1
Evolution of the ventilatory capacity in chronic bronchitis.慢性支气管炎通气能力的演变
Br Med J. 1967 Aug 12;3(5562):392-5. doi: 10.1136/bmj.3.5562.392.
2
Respiratory symptoms, bronchitis, and ventilatory capacity in men. An Anglo-Danish comparison, with special reference to differences in smoking habits.男性的呼吸道症状、支气管炎与通气能力。一项英-丹比较研究,特别关注吸烟习惯的差异。
Br Med J. 1960 Feb 13;1(5171):450-6. doi: 10.1136/bmj.1.5171.450.
3
AMERICAN EMPHYSEMA AND BRITISH BRONCHITIS. A STANDARDIZED COMPARATIVE STUDY.美国肺气肿与英国支气管炎。一项标准化比较研究。
Am Rev Respir Dis. 1964 Jul;90:1-13. doi: 10.1164/arrd.1964.90.1.1.
4
The histology of generalized pulmonary emphysema. I. The genesis of the early centrolobular lesion: focal emphysema.全小叶型肺气肿的组织学。I. 早期小叶中心性病变的发生:局灶性肺气肿。
Australas Ann Med. 1957 May;6(2):124-40. doi: 10.1111/imj.1957.6.2.124.
5
Clinical pattern of chronic bronchitis.慢性支气管炎的临床模式
Lancet. 1953 Sep 26;265(6787):639-43. doi: 10.1016/s0140-6736(53)90369-9.
6
Serial studies of 100 patients with chronic airway obstruction in London and Chicago.对伦敦和芝加哥的100例慢性气道阻塞患者进行的系列研究。
Thorax. 1967 Jul;22(4):327-35. doi: 10.1136/thx.22.4.327.
7
Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients.慢性阻塞性肺疾病的病程与预后。对200例患者的前瞻性研究。
N Engl J Med. 1969 Feb 20;280(8):397-404. doi: 10.1056/NEJM196902202800801.
8
The causes of death in chronic airway obstruction. I. The unreliability of death certificates and routine autopsies.
Am Rev Respir Dis. 1968 Oct;98(4):601-10. doi: 10.1164/arrd.1968.98.4.601.
9
The predictive value of a postal questionnaire on cardio-respiratory symptoms.
J Chronic Dis. 1970 Nov;23(5):411-21. doi: 10.1016/0021-9681(70)90025-1.
10
Cigarette smoking and changes in respiratory findings.
Arch Environ Health. 1970 Jul;21(1):50-7. doi: 10.1080/00039896.1970.10667191.